A clinical trial for efficacy and safety on carbon ion scanning beam therapy for locally advanced pancreatic cancer by endoscopic ultrasound-guided metal marker

A clinical trial for efficacy and safety on carbon ion scanning beam therapy for locally advanced pancreatic cancer by endoscopic ultrasound-guided metal marker - metal marker guided carbon ion scanning beam therapy for pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024690

Enrollment

Registered

2016-11-03

Start date

2016-11-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary pancreatic cancer

Interventions

1.endoscopic ultrasound-guided metal marker 2.carbon ion scanning beam therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.All patients must be willing and capable to provide informed consent to participate in the protocol. 2.All patients are planning to receive carbon-ion radiotherapy for pancreatic cancer 3.Age18-80years. 4.Performance status0-2.

Exclusion criteria

Exclusion criteria: 1.Main vessel is located along a needle puncture. 2.allergy to metal or anesthetic 3.Placement of a metal stent for relief of biliary obstruction (metal stents may be placed following completion of radiation therapy). 4.Active inflammatory bowel disease or active gastric/duodenal ulcer

Design outcomes

Primary

Measure	Time frame
Acute normal tissue damages	—

Countries

Japan

Contacts

Public ContactShigeru Yamada

National Institutes for Quantum and Radiological Science and Technology National Institutes for Radiological Science

yamada.shigeru@qst.go.jp043-206-3306

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026